Skip to main content

Laura Rubio Unguetti

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Laura Rubio Unguetti

Institutions of which they are part

Research technician
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Projects

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Elisabet Miro Casas, Marisol Ruiz Meana, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Fundación Eugenio Rodríguez Pascual
Funding: 25000
Reference: FERP/2024/RODRIGUEZ
Duration: 15/01/2025 - 14/01/2027

Inhibición del intercanviador sodio/calcio mitocondrial, NCLX, como estrategia terapéutica para reducir el daño miocárdico por isquemia-reperfusión durante el infarto de miocardio.

IP: Antonio Rodríguez Sinovas
Collaborators: Laia Yañez Bisbe, Remedios Rios Barrera, Laura Rubio Unguetti, Gino Freddy Sena Ganse
Funding agency: Instituto de Salud Carlos III
Funding: 127500
Reference: PI23/00260
Duration: 01/01/2024 - 31/12/2026

(NC-p38i) Nuevos fármacos para mejorar para mejorar el daño cardíaco inducido por isquemia-reperfusión y por quimioterapia con antraciclinas.

IP: Antonio Rodríguez Sinovas
Collaborators: Gino Freddy Sena Ganse, Laura Rubio Unguetti
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 157988.6
Reference: PLEC2022-009227
Duration: 01/12/2022 - 30/11/2025

Ministerio de Ciencia

Related news

The study, led by Vall d'Hebron, is the first in Spain to analyse the relationship between pregnancy complications and the risk of long-term cardiovascular diseases.

The consensus document is the result of multidisciplinary work that takes into account the risks associated with all stages of women's lives and the differences compared to men.

The study, which involved Vall d'Hebron, developed an action plan to efficiently allocate resources to patients most at risk of suffering this complication.

Related professionals

Xurxo Segura Navarro

Xurxo Segura Navarro

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Daniel Bravo Nieto

Daniel Bravo Nieto

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Javier Hernandez Losa

Javier Hernandez Losa

Predoctoral researcher
Translational Molecular Pathology
Read more
Eduard Mogas Viñas

Eduard Mogas Viñas

Growth and Development
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.